The Enterprise Value as of December 2025 (TTM) for Mydecine Innovations Group Inc. (MYCOF) is 18.04M

According to Mydecine Innovations Group Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 18.04M. This represents a change of 152.24% compared to the average of 7.15M of the last 4 quarters.

Mydecine Innovations Group Inc. (MYCOF) Historical Enterprise Value (quarterly & annually)

How has MYCOF Enterprise Value performed in the past?

The mean historical Enterprise Value of Mydecine Innovations Group Inc. over the last ten years is 17.89M. The current 18.04M Enterprise Value has changed 9.99% with respect to the historical average. Over the past ten years (40 quarters), MYCOF's Enterprise Value was at its highest in in the June 2021 quarter at 83.80M. The Enterprise Value was at its lowest in in the December 2016 quarter at -421607.00.

Mydecine Innovations Group Inc. (MYCOF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Mydecine Innovations Group Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Mydecine Innovations Group Inc. (MYCOF) Average Enterprise Value

How has MYCOF Enterprise Value performed in the past?

The current Enterprise Value of Mydecine Innovations Group Inc. (MYCOF) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Mydecine Innovations Group Inc. (MYCOF) Enterprise Value vs. Peers

How is MYCOF’s Enterprise Value compared to its peers?

Mydecine Innovations Group Inc.’s Enterprise Value is greater than China Health Industries Holdings, Inc. (5.11M), greater than Telescope Innovations Corp. (17.36M), greater than Herbal Dispatch Inc. (6.36M), less than Vivesto AB (69.29M), less than Biotricity, Inc. (26.00M), greater than Quest PharmaTech Inc. (7.62M), less than PT Kalbe Farma Tbk. (49.54T), greater than Gemina Laboratories Ltd. (15.54M), less than Valeo Pharma Inc. (57.68M), greater than BioQuest Corp. (6.26M),

Build a custom stock screener for Mydecine Innovations Group Inc. (MYCOF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mydecine Innovations Group Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Mydecine Innovations Group Inc. (MYCOF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Mydecine Innovations Group Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.